Association of tumour mutational burden with outcomes in patients with select advanced solid tumours treated with pembrolizumab in KEYNOTE-158

Authors :: Mei Chen
Marwan Fakih
Steven Kao
Jose A. Lopez-Martin
Deepti Aurora-Garg
F. Jin
Y-J. Bang
J.-P. Delord
Wilson H. Miller
J. Lopez
Hedy L. Kindler
Antoine Italiano
Manisha H. Shah
Sarina Anne Piha-Paul
Kazuhiko Nakagawa
Aurélien Marabelle
Ronnie Shapira-Frommer
H.C. Chung
Robert R. McWilliams
Kevin Norwood
Source :: Annals of Oncology. 30:v477-v478
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
medicine.medical_specialty
Surrogate endpoint
business.industry
Cancer
Hematology
Pembrolizumab
Neuroendocrine tumors
medicine.disease
Response Evaluation Criteria in Solid Tumors
Internal medicine
medicine
In patient
Mesothelioma
Nivolumab
business

Full Text Access

Tools